These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
8. Generic immunosuppression in transplantation: current evidence and controversial issues. El Hajj S; Kim M; Phillips K; Gabardi S Expert Rev Clin Immunol; 2015 May; 11(5):659-72. PubMed ID: 25817258 [TBL] [Abstract][Full Text] [Related]
9. Methods, strengths, weaknesses, and limitations of bioequivalence tests with special regard to immunosuppressive drugs. van Gelder T; Gabardi S Transpl Int; 2013 Aug; 26(8):771-7. PubMed ID: 23441971 [TBL] [Abstract][Full Text] [Related]
10. Evaluation of clinical and safety outcomes associated with conversion from brand-name to generic tacrolimus in transplant recipients enrolled in an integrated health care system. Spence MM; Nguyen LM; Hui RL; Chan J Pharmacotherapy; 2012 Nov; 32(11):981-7. PubMed ID: 23074134 [TBL] [Abstract][Full Text] [Related]
11. European Society for Organ Transplantation Advisory Committee recommendations on generic substitution of immunosuppressive drugs. van Gelder T; Transpl Int; 2011 Dec; 24(12):1135-41. PubMed ID: 22032583 [No Abstract] [Full Text] [Related]
12. Is all "skin in the game" fair game? The problem with "non-preferred" generics. Oster G; Fendrick AM Am J Manag Care; 2014 Sep; 20(9):693-5. PubMed ID: 25365744 [No Abstract] [Full Text] [Related]
13. Generic medicines in the Malaysian health care system: Opportunities and challenges. Wong ZY; Alrasheedy AA; Hassali MA; Saleem F Res Social Adm Pharm; 2016; 12(5):807-10. PubMed ID: 27157864 [No Abstract] [Full Text] [Related]
14. Is There Evidence to Support Brand to Generic Interchange of the Mycophenolic Acid Products? Phillips K; Reddy P; Gabardi S J Pharm Pract; 2017 Feb; 30(1):9-16. PubMed ID: 26043743 [TBL] [Abstract][Full Text] [Related]
15. Generic drug products in paediatrics: Where are the data? Illamola SM; Birnbaum AK; Sherwin CM Br J Clin Pharmacol; 2019 Sep; 85(9):1871-1873. PubMed ID: 31281980 [No Abstract] [Full Text] [Related]
16. Generic immunosuppressants: the European perspective. Christians U Transplant Proc; 1999 May; 31(3A Suppl):19S-22S. PubMed ID: 10330954 [No Abstract] [Full Text] [Related]
17. Generic drugs for the treatment of ocular conditions: changing the treatment landscape. Aref AA Expert Rev Clin Pharmacol; 2014 Sep; 7(5):551-3. PubMed ID: 24957466 [TBL] [Abstract][Full Text] [Related]
18. Generic maintenance immunosuppression in solid organ transplant recipients. Ensor CR; Trofe-Clark J; Gabardi S; McDevitt-Potter LM; Shullo MA Pharmacotherapy; 2011 Nov; 31(11):1111-29. PubMed ID: 22026398 [TBL] [Abstract][Full Text] [Related]
20. What Is the Future of Generics in Transplantation? van Gelder T Transplantation; 2015 Nov; 99(11):2269-73. PubMed ID: 26050017 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]